Investigations focusing on the CRF01_AE subtype highlight a significantly rapid disease progression from HIV-1 infection to clinical AIDS stage and a drop in CD4+ T cell count below 200/μL, with median times of 7.2 years and 6.5 years, respectively (Rangsin et al., 2007). This evidence concerns the gene CD4 and AIDS.